MojicaFJM, MontoliuL. On the Origin of CRISPR-Cas technology: from prokaryotes to mammals. Trends Microbiol. 2016; 24:811–820. DOI: 10.1016/j.tim.2016.06.005.
2.
JarrettW. The Concordat on openness and its benefits to animal research. Lab Anim (NY). 2016; 45:201–202. DOI: 10.1038/laban.1026.
3.
HirschF, LévyY, ChneiweissH. CRISPR-Cas9: A European position on genome editing. Nature. 2017; 541:3–0. DOI: 10.1038/541030c.
4.
ChneiweissH, HirschF, MontoliuL, et al.Fostering responsible research with genome editing technologies: a European perspective. Transgenic Res. 2017; 26:709–713. DOI: 10.1007/s11248-017-0028-z.
5.
de LecuonaI, CasadoM, MarfanyG, et al.Gene Editing in humans: towards a global and inclusive debate for responsible research. Yale J Biol Med. 2017; 90:673–681. eCollection 2017 Dec.
6.
JasanoffS, HurlbutJB. A global observatory for gene editing. Nature. 2018; 555:435–437. DOI: 10.1038/d41586-018-03270-w.
